Experts outline emerging vaccine technologies and multi-target formulations, indicating significant future impacts.
As the vaccines field continues to evolve, new technologies, targets, and delivery strategies are reshaping both research priorities and implementation pathways. We asked members of the Vaccine Insights Editorial Advisory Board to reflect on the areas shaping their current work and the developments they believe will influence the field in the years ahead. "Based on current trends, I expect increased focus on vaccine formulations that incorporate multiple antigens or immunogens, potentially addressing several diseases or stages within a single product." - Rajender Jena, Head Malaria Vaccines (Quality Control), Serum Institute of India Pvt Ltd, India
No takes yet. Share an insight, caveat, or question.
Racine et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: